Abbott (NYSE:ABT) released earnings on June 30, 2005.

Income Statement Highlights (What's this?)

Avg. Est. Q2 2005 Q2 2004 % Change
Sales $5,280,000 $5,523,800 $4,703,049 +17.5%
Net Profit -- $877,052 $634,258 +38.3%
EPS $0.57 $0.56 $0.40 +40.0%
(Figures in thousands, except per-share data)

Margin Checkup (What's this?)

Q2 2005 Q2 2004 % Change
Gross Margin 52.35% 56.01% -3.66%
Op. Margin 19.82% 16.93% +2.89%
Net Margin 15.88% 13.49% +2.39%

Balance Sheet Highlights (What's this?)

No balance sheet provided.

Related Companies:

  • Pfizer (NYSE:PFE)
  • Merck (NYSE:MRK)
  • Eli Lilly (NYSE:LLY)
  • Bristol-Myers Squibb (NYSE:BMY)
  • Schering-Plough (NYSE:SGP)

Related Foolishness:

If you would like our Foolish analysis of similar companies, why not take a 30-day free trial to Motley Fool Rule Breakers?

Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check for more of our in-depth discussion of what the numbers mean.

At the time of publication, John Reeves did not own shares in any of the companies mentioned. Fool rules are here.